BNP Paribas Financial Markets Acquires 1,690,827 Shares of Tilray Inc (NASDAQ:TLRY)

BNP Paribas Financial Markets grew its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 1,314.1% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,819,494 shares of the company’s stock after buying an additional 1,690,827 shares during the period. BNP Paribas Financial Markets owned approximately 0.20% of Tilray worth $3,202,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Tilray by 3.5% during the first quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock worth $8,707,000 after acquiring an additional 117,891 shares in the last quarter. Bank of Montreal Can boosted its position in shares of Tilray by 0.3% during the 3rd quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock worth $3,787,000 after purchasing an additional 7,406 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Tilray by 2.6% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,487,500 shares of the company’s stock valued at $2,617,000 after buying an additional 37,300 shares during the period. TD Asset Management Inc increased its position in Tilray by 8.1% in the 2nd quarter. TD Asset Management Inc now owns 1,373,045 shares of the company’s stock valued at $2,278,000 after buying an additional 103,207 shares in the last quarter. Finally, CIBC Asset Management Inc raised its stake in Tilray by 4.2% during the 3rd quarter. CIBC Asset Management Inc now owns 908,098 shares of the company’s stock worth $1,599,000 after buying an additional 36,799 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Price Performance

Shares of NASDAQ TLRY opened at $1.30 on Friday. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of -4.81 and a beta of 2.08. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. Tilray Inc has a fifty-two week low of $1.27 and a fifty-two week high of $2.97. The firm’s 50-day simple moving average is $1.54 and its 200 day simple moving average is $1.70.

Tilray (NASDAQ:TLRY) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company had revenue of $200.00 million for the quarter, compared to analyst estimates of $218.70 million. During the same quarter last year, the company earned ($0.10) earnings per share. The company’s revenue for the quarter was up 13.0% on a year-over-year basis. As a group, research analysts anticipate that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reduced their price objective on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.

Insiders Place Their Bets

In other Tilray news, CFO Carl A. Merton acquired 26,000 shares of Tilray stock in a transaction on Friday, November 15th. The stock was purchased at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the purchase, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.87% of the company’s stock.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.